azauridine has been researched along with Scleroderma, Systemic in 3 studies
Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catalanotto, FA | 1 |
| Slavik, M | 3 |
| Danilson, D | 1 |
| Keiser, HR | 3 |
| Henkin, RI | 2 |
| Lovenberg, W | 1 |
| Danilson, DA | 1 |
3 other studies available for azauridine and Scleroderma, Systemic
| Article | Year |
|---|---|
Changes in preference for NaCl following administration of 6-azauridine and 6-azauridine triacetate.
Topics: Administration, Oral; Adult; Animals; Azauridine; Copper; Differential Threshold; Female; Gastric La | 1975 |
Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetate.
Topics: Adult; Alanine; Amino Acids; Aminobutyrates; Azauridine; Female; Homocystine; Humans; Middle Aged; S | 1973 |
Alterations in metabolism of copper and zinc after administration of 6-azauridine triacetate.
Topics: Acetates; Adult; Azauridine; Copper; Female; Humans; Kidney; Middle Aged; Scleroderma, Systemic; Spe | 1973 |